Ph.D. is a Professor of Anatomy, Physiology and Genetics and Professor of Neuroscience, at Uniformed Services University of the Health Sciences
Professor Anders is an internationally recognized expert in Photobiomodulation research and has served as invited Chair and speaker globally. Her specialty is peripheral and central nervous system injury and repair mechanisms, and light tissue interactions. Dr. Anders received her Ph.D. in Anatomy from the University of Maryland Medical School then joined the National Institutes of Health in the Laboratory of Neuropathology and Neuroanatomical Sciences, NINDS. Currently she is funded by the Department of Defense to investigate the use Photobiomodulation Therapy as a non-invasive, non-pharmaceutical alternative for the management of neuropathic pain.
Professor Anders has served and continues to serve as a member of numerous state, national, and international scientific review panels including the National Institutes of Health, the Food and Drug Administration, Veterans Affairs, the Department of Defense, and the Congressionally Directed Medical Research Programs. She also serves on the Executive Councils and Scientific Advisory Boards of numerous international laser conferences. She is the past president of the North American Association of Laser Therapy, a founding member of the International Academy of Laser Medicine and Surgery, Past President of the American Society of Lasers in Medicine and Surgery and Past Director of the Optical Society of America Photobiomodulation Technical Group. She has recently been appointed as a board member of the International Society of Lasers in Medicine and Surgery and currently serves on the Advisory Board of the OSA Photobiomodulation Technical Group. She is a Senior Editor of Photobiomodulation, Photomedicine and Laser Surgery, Associate Editor of Lasers in Medical Science, and Frontiers in Neuroscience (Neurogenesis) and on the editorial board of Physiotherapy Practice and Research and Laser Therapy. She has published over 70 peer reviewed articles.
Hello Dr. Anders, thank you for that presentation. When you asked if the 4 cm brain penetration delivered a therapeutic dose, did you ever answer the question? This is from the slide Results 808 nm Wavelength Penetration in the Cadaver Brain. What fluence was delivered and did you consider it therapeutic? Or is that an open question? thank you. - Caroline
Why is it then that WALT still recommends 4 joules per point even when treating deeper tissues? Shouldn' t we take take the loss of energy because of the depth of target tissue into considerstion? Do you think that the inevitable overdoding st the skin could be a problem?
All good questions. I do believe that the WALT recommendations need to be updated. Dr. Arany made a valiant effort to make this happen but it was never completed. Yes definitely you must consider the loss of light through the tissues above the target. As you know you can under dose PBMt and get no or minimal effect and you can definitely overdose causing inhibition. Further very high doses at the skin in the near infrared range can cause thermal damage to the skin.